Korean J Blood Transfus.
2010 Aug;21(2):158-164.
Using Genotyping to Identify an A1B(weak) Blood Group
- Affiliations
-
- 1Department of Laboratory Medicine, School of Medicine, Korea University, Seoul, Korea. malarim@korea.ac.kr
Abstract
- Since an exact ABO blood type match is essential for transfusion therapy, any ABO discrepancies should be resolved prior to the issuing of blood. The authors confirmed the ABO blood group of a 50-year-old male using genotyping. On a routine blood group test, the cell type was A+; however, anti-B was undetected in his serum. To determine the cause of this ABO discrepancy, an adsorption elution test and saliva test were performed. The presence of a weak B substance was suspected despite no evidence of the B antigen on red blood cells. Polymerase-chain-reaction restriction-fragment-length-polymorphism (PCR-RFLP) and sequencing analysis of exons 6 and 7 demonstrated that his blood type was A1Bweak (the A allele tested as the A105 subtype, while the B allele was most similar to the B302 subtype). Again, using genotyping, we subsequently confirmed the A1Bweak blood type in a leukemic patient who was in complete remission.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Detection of an AB(weak) Blood Group by Genotyping
- Weak D type 33 Found in a Patient with a Weak D Phenotype: The First Case in Korea
- An Algorithm to Work-up ABO Subgroups Presenting as Weak B in a Real-world Laboratory: A Case with a Weak B Phenotype Harboring B101/O04-variant Alleles
- Preparation of Glutaraldehyde-Treated Red Blood Cells Expressing Weak ABO and RhD Antigens for Use in Tube Methods
- The study of RHD gene mutation in weak D
